Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

about

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

Item

http://www.wikidata.org/entity/Q58792528

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

@en

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A

@nl

type

Item

label

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

@en

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A

@nl

prefLabel

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

@en

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A

@nl

P1476

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A (GIVA cPLA)

@en

P2093

Anastasia Psarra

http://www.w3.org/2001/XMLSchema#string

Edward A Dennis

http://www.w3.org/2001/XMLSchema#string

George Kokotos

http://www.w3.org/2001/XMLSchema#string

Gerasimia Galiatsatou

http://www.w3.org/2001/XMLSchema#string

Maroula G Kokotou

http://www.w3.org/2001/XMLSchema#string

Varnavas D Mouchlis

http://www.w3.org/2001/XMLSchema#string

P2860

Eicosanoid storm in infection and inflammation

Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.

Cytosolic phospholipase A₂: physiological function and role in disease.

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders.

Cytosolic phospholipase A2α promotes pulmonary inflammation and systemic disease during Streptococcus pneumoniae infection.

Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo.

P304

8843-8853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSOMEGA.8B01214

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30197994

http://www.w3.org/2001/XMLSchema#string

P932

6120731

http://www.w3.org/2001/XMLSchema#string